Please login to the form below

Not currently logged in
Email:
Password:

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

edit-Dario-EklundVifor Pharma has named Dario Eklund as their head of international business operations.

Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing and the Gintuit business unit.

Prior to that, he was general manager of Switzerland for Aventis Pharma, until its 2004 merger with Sanofi, and earlier in his career he held a number of commercial and management roles for Novartis.

Eklund will report directly to Vifor Pharma CEO Søren Tulstrup and will be based at company's headquarters in Zurich, Switzerland.

Meanwhile, Vifor has also appointed Abdul Mullick to the position of head of global marketing. His previous roles include VP and general manager of endocrinology and cardiology in the rare diseases division of Sanofi in Boston, where he led the US and international operations.

18th September 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics